Cargando…
Non-alcoholic fatty liver disease and lipotoxicity
Non-alcoholic fatty liver disease (NAFLD) has become the most common liver pathology worldwide due to the rising prevalence of obesity. This term includes changes from simple steatosis to steatohepatitis and fibrosis. It was previously thought to be a hepatic manifestation of metabolic syndrome, but...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122097/ https://www.ncbi.nlm.nih.gov/pubmed/34027109 http://dx.doi.org/10.5114/ceh.2021.104441 |
_version_ | 1783692514675392512 |
---|---|
author | Wasilewska, Natalia Lebensztejn, Dariusz Marek |
author_facet | Wasilewska, Natalia Lebensztejn, Dariusz Marek |
author_sort | Wasilewska, Natalia |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) has become the most common liver pathology worldwide due to the rising prevalence of obesity. This term includes changes from simple steatosis to steatohepatitis and fibrosis. It was previously thought to be a hepatic manifestation of metabolic syndrome, but recent literature describes this relation as much more complex and bi-directional. Development of NAFLD is associated with other metabolic syndrome components but it can also exacerbate insulin resistance and increase cardiovascular risk. Recently a lot of attention is brought to the role of lipids and lipotoxicity in pathogenesis and progression of non-alcoholic fatty disease. It seems that some lipid classes can be protective against liver injury while others are harmful in excessive amounts. This study presents an overview of the main lipids involved in the pathogenesis of non-alcoholic fatty liver disease and summarizes their association with lipotoxicity, insulin resistance, oxidative stress and other processes responsible for its progression. |
format | Online Article Text |
id | pubmed-8122097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-81220972021-05-21 Non-alcoholic fatty liver disease and lipotoxicity Wasilewska, Natalia Lebensztejn, Dariusz Marek Clin Exp Hepatol Review Paper Non-alcoholic fatty liver disease (NAFLD) has become the most common liver pathology worldwide due to the rising prevalence of obesity. This term includes changes from simple steatosis to steatohepatitis and fibrosis. It was previously thought to be a hepatic manifestation of metabolic syndrome, but recent literature describes this relation as much more complex and bi-directional. Development of NAFLD is associated with other metabolic syndrome components but it can also exacerbate insulin resistance and increase cardiovascular risk. Recently a lot of attention is brought to the role of lipids and lipotoxicity in pathogenesis and progression of non-alcoholic fatty disease. It seems that some lipid classes can be protective against liver injury while others are harmful in excessive amounts. This study presents an overview of the main lipids involved in the pathogenesis of non-alcoholic fatty liver disease and summarizes their association with lipotoxicity, insulin resistance, oxidative stress and other processes responsible for its progression. Termedia Publishing House 2021-03-25 2021-03 /pmc/articles/PMC8122097/ /pubmed/34027109 http://dx.doi.org/10.5114/ceh.2021.104441 Text en Copyright © 2021 Clinical and Experimental Hepatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Review Paper Wasilewska, Natalia Lebensztejn, Dariusz Marek Non-alcoholic fatty liver disease and lipotoxicity |
title | Non-alcoholic fatty liver disease and lipotoxicity |
title_full | Non-alcoholic fatty liver disease and lipotoxicity |
title_fullStr | Non-alcoholic fatty liver disease and lipotoxicity |
title_full_unstemmed | Non-alcoholic fatty liver disease and lipotoxicity |
title_short | Non-alcoholic fatty liver disease and lipotoxicity |
title_sort | non-alcoholic fatty liver disease and lipotoxicity |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122097/ https://www.ncbi.nlm.nih.gov/pubmed/34027109 http://dx.doi.org/10.5114/ceh.2021.104441 |
work_keys_str_mv | AT wasilewskanatalia nonalcoholicfattyliverdiseaseandlipotoxicity AT lebensztejndariuszmarek nonalcoholicfattyliverdiseaseandlipotoxicity |